The Center for Disease Control (CDC) intends to award, on a sole source basis a purchase order to Roche Diagnostic Corporation located at 9115 Hague Road, Indianapolis, IN 46256-1025. The Purchase Order will be issued to acquire the following:
1. Roche Linear Array HPV Genotype Kits, QTY: 84 Each,material No 04472209190
2. Roche Linear Array Detection Kits, QTY: 43 Each Material No. 03378012190

These commercial products are being procured using simplified acquisition procedures in accordance with FAR Part 13. The authority for this sole source acquisition is FAR Subpart 13.106-1(b). Justification for other than full and open competition is considered due to the continued need to match existing products for ongoing studies being conducted by the CDC. Failure to procure existing materials in batch lots currently offered by Roche Diagnostics will alter or contaminate assays required for ongoing research being conducted by the CDC. It is believed that the Roche Linear Array Kits are the only product currently available on the commercial market that is capable of detecting and tying 37 different HPV types. It is further believed that failure to acquire the Roche kits by specific lot number will require CDC/NCZVED Division of Viral and Rickettsial Disease to develop or validate alternative assays for detection and typing of HPV at a cost significantly greater than acquiring these commercially available Roche kits. It is believed that any data collected on the pre-vaccine type specific prevalence HPV using an alternative product cannot be directly compared to results of other pre existing assay results thus skewing or terminating research efforts. This is not a request for competitive proposals and no solicitation is available. Firms that believe they can provide Roche Linear Array Kits by serial lot number are encouraged to identify themselves and give written notice to the Contracting Officer on or before 9:00 AM (Eastern Standard Time) on September 12, 2011. Determination by the Government not to compete this proposed action based on any responses to this notice is solely within the discretion of the U.S. Government. Respondents will assume all costs of preparing a response to this notice. The U.S Government assumes no financial obligation for the preparation and distribution of any response to this notice.
Inquires may be sent to Cornelius Willis by email at [email protected] or by FAX to 412-386-6429

Bid Protests Not Available